Scientists delve deeper into how vaccines work against leishmaniasis

Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.

MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process – Biotech Investments

MorphoSys AG / Key word(s): Capital Increase Ad hoc: MorphoSys AG Launches Cash Capital Increase by way of Accelerated Bookbuilding Process 13-Dec-2023 / 22:01 CET/CEST

December 14, 2023

Psilocybin’s Effects on the Auditory Cortex in Mice | Psychedelic Invest

Recent research has uncovered significant insights into how psilocybin impacts the auditory cortex in mouse models. Psilocybin, a natural psychedelic compound found in over 200

July 10, 2024

Next-gen intranasal vaccine takes on measles, mumps, and multiple COVID-19 variants in one shot

Researchers developed an intranasal trivalent measles-mumps-SARS-CoV-2 vaccine that provides robust protection against multiple coronavirus variants. Leveraging the established measles-mumps-rubella platform, this vaccine demonstrates broad and

October 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.